These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8357997)

  • 1. Formation by the endothelium of prostacyclin, nitric oxide and endothelin.
    Vane JR; Botting RM
    J Lipid Mediat; 1993; 6(1-3):395-404. PubMed ID: 8357997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by nitric oxide-releasing compounds of prostacyclin production in human endothelial cells.
    Kosonen O; Kankaanranta H; Malo-Ranta U; Ristimäki A; Moilanen E
    Br J Pharmacol; 1998 Sep; 125(2):247-54. PubMed ID: 9786495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive mediators derived from the endothelium.
    Botting R; Vane JR
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():11-4. PubMed ID: 2514650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of chemical mediators released by the endothelium in the control of the cardiovascular system.
    Vane JR; Botting RM
    Int J Tissue React; 1992; 14(2):55-64. PubMed ID: 1399322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of vanadate on prostacyclin and endothelin-1 production and protein-tyrosine phosphorylation in human endothelial cells.
    Shimizu H; Takayama H; Lee JD; Satake K; Taniguchi T; Yamamura H; Nakamura T
    Thromb Haemost; 1994 Dec; 72(6):973-8. PubMed ID: 7740471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imbalance between the endothelial cell-derived contracting factors prostacyclin and angiotensin II and nitric oxide/cyclic GMP in human primary varicosis.
    Schuller-Petrovic S; Siedler S; Kern T; Meinhart J; Schmidt K; Brunner F
    Br J Pharmacol; 1997 Oct; 122(4):772-8. PubMed ID: 9375976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretory functions of the vascular endothelium.
    Vane JR; Botting RM
    J Physiol Pharmacol; 1992 Sep; 43(3):195-207. PubMed ID: 1493252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosynthesis and interaction of endothelium-derived vasoactive mediators.
    Thiemermann C
    Eicosanoids; 1991; 4(4):187-202. PubMed ID: 1789995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of nitric oxide and prostacyclin synthesis in endothelial cells.
    Busse R; Hecker M; Fleming I
    Arzneimittelforschung; 1994 Mar; 44(3A):392-6. PubMed ID: 8185712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of endothelial mediators on the vascular smooth muscle and circulating platelets and blood cells.
    Warner TD
    Int Angiol; 1996 Jun; 15(2):93-9. PubMed ID: 8803631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelins: potent releasers of prostacyclin and EDRF.
    Botting RM; Vane JR
    Pol J Pharmacol Pharm; 1990; 42(3):203-18. PubMed ID: 2263532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium.
    Mitchell JA; Ali F; Bailey L; Moreno L; Harrington LS
    Exp Physiol; 2008 Jan; 93(1):141-7. PubMed ID: 17965142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelium-dependent modulation of responses to endothelin-I in human veins.
    Haynes WG; Webb DJ
    Clin Sci (Lond); 1993 Apr; 84(4):427-33. PubMed ID: 8482047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide as a regulator of prostacyclin synthesis in cultured rat heart endothelial cells.
    Sievi E; Lähteenmäki TA; Alanko J; Vuorinen P; Vapaatalo H
    Arzneimittelforschung; 1997 Oct; 47(10):1093-8. PubMed ID: 9368700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Furosemide enhances the release of endothelial kinins, nitric oxide and prostacyclin.
    Wiemer G; Fink E; Linz W; Hropot M; Schölkens BE; Wohlfart P
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1611-5. PubMed ID: 7996475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyaspartoyl.L-arginine enhances prostacyclin synthesis in rat aortic endothelial cells.
    Tang Z; Yang J; Liu X; Wang Y; Peng S
    Eur J Pharmacol; 2008 Dec; 601(1-3):124-8. PubMed ID: 19026630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelium.
    Shah AM
    Br J Hosp Med; 1992 Nov 4-17; 48(9):540-9. PubMed ID: 1477710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory mechanisms of the vascular endothelium: an update.
    Vane JR; Botting RM
    Pol J Pharmacol; 1994; 46(6):499-21. PubMed ID: 7620513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procoagulant albumin increases vascular endothelial cell prostacyclin secretion.
    Gubler DB; Ahlstrom CR; Liu L; Zhou JF; Parker CJ; Rodgers GM
    Thromb Haemost; 1995 Dec; 74(6):1573-7. PubMed ID: 8772239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulsatile flow increases the expression of eNOS, ET-1, and prostacyclin in a novel in vitro coculture model of the retinal vasculature.
    Walshe TE; Ferguson G; Connell P; O'Brien C; Cahill PA
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):375-82. PubMed ID: 15623798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.